Fundraising FoxPrevail Venture Capital — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases.
BiotechDeep TechHealthtechGaithersburg, US
Samir N. Khleif(Founder & CEO)inRamy Ibrahim(Chief Medical and Strategy Officer)inMikayel Mkrichyan(Senior Vice President of Science and Discovery)Sarah Sharman(Vice President of IP Legal Affairs)
BoardSean Parker(Director)Elena Viboch(Director)in
Co-investorsCatalio Capital Management, LPGeneral CatalystHAWKTAILLauder PartnersAlexandriaCatalio Capital Management+3 more
.png)
Global Settlement Network (GSX) provides blockchain-based settlement infrastructure that lets regulated banks and governments issue digital currency, settle tokenized assets, and move value across borders with near-instant finality.
Crypto & Web3Enterprise SoftwareFintech
Co-investorsOutliers VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.